PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.
Keggenhoff FL, Castven D, Becker D, Stojkovic S, Castven J, Zimpel C, Straub BK, Gerber T, Langer H, Hähnel P, Kindler T, Fahrer J, O'Rourke CJ, Ehmer U, Saborowski A, Ma L, Wang XW, Gaiser T, Matter MS, Sina C, Derer S, Lee JS, Roessler S, Kaina B, Andersen JB, Galle PR, Marquardt JU.
Keggenhoff FL, et al. Among authors: becker d.
Gut. 2024 Sep 9;73(10):1712-1724. doi: 10.1136/gutjnl-2023-331237.
Gut. 2024.
PMID: 38857989
Free PMC article.